Eoptolink Launches 1.6T OSFP 2VR4 Transceivers Using 200G VCSELs
Vertical Cavity Surface Emitting Lasers (VCSELs) operating at 850nm are the dominant optical laser technology for less than 100m transmission distance of short reach connectivity. At OFC 2025 in
VCSEL lasers operating at 106Gb/s are incorporated in many of today's short reach links built with 400G SR4 and 800G SR8 optical transceivers. The next evolutionary step is to increase the data-rate in these connections to 212 Gb/s.
The 1.6T OSP 2VR4 transceiver has two optical MPO-12 interfaces each operating at 800G using optical four lanes at 212Gb/s. The transceiver offers a suitable method to migrate legacy multimode installations to newer switch platforms.
"Eoptolink continues to lead the way as an optical transceiver innovator and we are excited to get early access to this 200G VCSEL technology", explains
We will be showing live demonstrations of a 1.6T, 800G, LPO, LRO and MCF optical transceiver solutions, at the Eoptolink booth #2943 at OFC 2025,
About Eoptolink
Eoptolink Technology Inc., Ltd. (SZSE: 300502) is a leading innovator and provider of advanced optical transceiver solutions for data center, enterprise and telecom networks. Eoptolink is dedicated to research, develop, manufacture and markets a diverse portfolio of high-performance optical transceivers for AI/ML Cluster, Cloud Data Center, 4G/5G wireless, Transport & Datacom and FTTX applications all over the world.
Contact Us
USA: 3191 Laurelview Court,
Thailand: 390/21 Moo 2,
E-mail: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/eoptolink-launches-1-6t-osfp-2vr4-transceivers-using-200g-vcsels-302414876.html
SOURCE Eoptolink Technology Inc., Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StrongMind Unveils StrongMind CoursePro, an AI-Powered Course Creation Platform, at DLAC Ignite
- Sun Pharma Announces UNLOXCYT® (cosibelimab-ipdl) Has Received a Category 2A Preferred Designation in the Updated NCCN Guidelines for Locally Advanced Cutaneous Squamous Cell Carcinoma (laCSCC) Patie
- ClearCast Debuts Market's 1st AI Listening Aid: Hear the Person, Not the Room
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share